Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colleen Hadigan

Showing results (71-80 of 95) with videos related to

Pageof 10
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|March 29, 2013
Influence of low-dose ritonavir with and without darunavir on the pharmacokinetics and pharmacodynamics of inhaled beclomethasoneSarita D Boyd, Colleen Hadigan, Maryellen McManus, et al.
AIDS (London, England)|July 17, 2007
Dietary fat intake and relationship to serum lipid levels in HIV-infected patients with metabolic abnormalities in the HAART eraTisha Joy, Hester M Keogh, Colleen Hadigan, et al.
Antimicrobial Agents and Chemotherapy|August 30, 2017
Differential Influence of the Antiretroviral Pharmacokinetic Enhancers Ritonavir and Cobicistat on Intestinal P-Glycoprotein Transport and the Pharmacokinetic/Pharmacodynamic Disposition of DabigatranParag Kumar, Lori A Gordon, Kristina M Brooks, et al.
Cardiorenal Medicine|April 5, 2018
Personalized Statin Therapy and Coronary Atherosclerotic Plaque Burden in Asymptomatic Low/Intermediate-Risk IndividualsRanganath Muniyappa, Radwa A Noureldin, Khaled Z Abd-Elmoniem, et al.
HIV Medicine|March 30, 2023
The role of HIV as a risk modifier for coronary endothelial function in young adultsKhaled Z Abd-Elmoniem, Teja Yeramosu, Julia B Purdy, et al.
The Journal of Infectious Diseases|May 13, 2015
Abnormal Myocardial Function Is Related to Myocardial Steatosis and Diffuse Myocardial Fibrosis in HIV-Infected AdultsDiana K Thiara, Chia Ying Liu, Fabio Raman, et al.
Antiviral Therapy|July 31, 2019
Long-term changes in hepatic fibrosis following hepatitis C viral clearance in patients with and without HIVJulia B Balmaceda, Julia Aepfelbacher, Olivia Belliveau, et al.
Journal of Clinical Immunology|April 16, 2011
Coronary artery abnormalities in Hyper-IgE syndromeAlexandra F Freeman, Elizabeth Mannino Avila, Pamela A Shaw, et al.
AIDS Research and Human Retroviruses|June 26, 2018
Early Presence of HIV-1 Subtype C in Washington, D.CZehava Grossman, Sheryl-Vi Rico, Katherine Cone, et al.
The Journal of Infectious Diseases|September 11, 2019
Metabolic Changes in Chronic Hepatitis C Patients Who Carry IFNL4-ΔG and Achieve Sustained Virologic Response With Direct-Acting Antiviral TherapyBenjamin Emmanuel, Samer S El-Kamary, Laurence S Magder, et al.
Pageof 10

Showing results (71-80 of 95) with videos related to

Sort By:
Pageof 10
Journal of Acquired Immune Deficiency Syndromes (1999)|March 29, 2013
Influence of low-dose ritonavir with and without darunavir on the pharmacokinetics and pharmacodynamics of inhaled beclomethasoneSarita D Boyd, Colleen Hadigan, Maryellen McManus, et al.
AIDS (London, England)|July 17, 2007
Dietary fat intake and relationship to serum lipid levels in HIV-infected patients with metabolic abnormalities in the HAART eraTisha Joy, Hester M Keogh, Colleen Hadigan, et al.
Antimicrobial Agents and Chemotherapy|August 30, 2017
Differential Influence of the Antiretroviral Pharmacokinetic Enhancers Ritonavir and Cobicistat on Intestinal P-Glycoprotein Transport and the Pharmacokinetic/Pharmacodynamic Disposition of DabigatranParag Kumar, Lori A Gordon, Kristina M Brooks, et al.
Cardiorenal Medicine|April 5, 2018
Personalized Statin Therapy and Coronary Atherosclerotic Plaque Burden in Asymptomatic Low/Intermediate-Risk IndividualsRanganath Muniyappa, Radwa A Noureldin, Khaled Z Abd-Elmoniem, et al.
HIV Medicine|March 30, 2023
The role of HIV as a risk modifier for coronary endothelial function in young adultsKhaled Z Abd-Elmoniem, Teja Yeramosu, Julia B Purdy, et al.
The Journal of Infectious Diseases|May 13, 2015
Abnormal Myocardial Function Is Related to Myocardial Steatosis and Diffuse Myocardial Fibrosis in HIV-Infected AdultsDiana K Thiara, Chia Ying Liu, Fabio Raman, et al.
Antiviral Therapy|July 31, 2019
Long-term changes in hepatic fibrosis following hepatitis C viral clearance in patients with and without HIVJulia B Balmaceda, Julia Aepfelbacher, Olivia Belliveau, et al.
Journal of Clinical Immunology|April 16, 2011
Coronary artery abnormalities in Hyper-IgE syndromeAlexandra F Freeman, Elizabeth Mannino Avila, Pamela A Shaw, et al.
AIDS Research and Human Retroviruses|June 26, 2018
Early Presence of HIV-1 Subtype C in Washington, D.CZehava Grossman, Sheryl-Vi Rico, Katherine Cone, et al.
The Journal of Infectious Diseases|September 11, 2019
Metabolic Changes in Chronic Hepatitis C Patients Who Carry IFNL4-ΔG and Achieve Sustained Virologic Response With Direct-Acting Antiviral TherapyBenjamin Emmanuel, Samer S El-Kamary, Laurence S Magder, et al.
Pageof 10